Biologics for Severe Asthma: Treatment-Specific Effects Are Important in Choosing a Specific Agent

2019 ◽  
Vol 7 (5) ◽  
pp. 1379-1392 ◽  
Author(s):  
James G. Krings ◽  
Mary Clare McGregor ◽  
Leonard B. Bacharier ◽  
Mario Castro
The Lancet ◽  
2005 ◽  
Vol 365 (9463) ◽  
pp. 974-976 ◽  
Author(s):  
Liam G Heaney ◽  
Douglas S Robinson

Author(s):  
J Ramos Rodríguez ◽  
S García Gil ◽  
L Cantarelli ◽  
J González García ◽  
C Romero Delgado ◽  
...  

2007 ◽  
Vol 119 (1) ◽  
pp. S173
Author(s):  
Y. Ogawa ◽  
E.G. Brooks ◽  
L. Williams ◽  
J. Lynch ◽  
J.B. Zwischenberger

2019 ◽  
Vol 5 (1) ◽  
pp. 023-026
Author(s):  
M Serao ◽  
R Vigliarolo ◽  
T Trequattrini ◽  
A Succu ◽  
M Lilli

2020 ◽  
Vol 14 (7) ◽  
pp. 499-502
Author(s):  
Salvatore Fuschillo ◽  
Enrico Heffler ◽  
Mauro Maniscalco

2019 ◽  
Vol 9 (7) ◽  
pp. 78 ◽  
Author(s):  
Amelia Licari ◽  
Riccardo Ciprandi ◽  
Gianluigi Marseglia ◽  
Giorgio Ciprandi

Emotional problems, such as anxiety and depression, are a relevant co-morbidity in severe asthma. Anxiety and depression may also be common in the parents of asthmatic adolescents. The current study evaluated anxious and depressive symptoms in 40 adolescents suffering from severe asthma, and in their parents, before and after 1 year of treatment, tailored according to validated asthma guidelines. We used the HADS (Hospital Anxiety Depression Scale) questionnaire for the adolescents, and HADS, STAY (State-Trait Anxiety Inventory), and BDI (Beck Depression Inventory) questionnaires for their parents. We also considered the grade of asthma severity before and after 1 year of treatment. The current study demonstrated that anxiety and depression are common in both the adolescents suffering from severe asthma and their parents. Anxious and depressive symptoms were correlated between adolescents and their parents. Asthma treatment improved the asthma severity in almost all adolescents. However, the parental anxiety and depression remained unchanged at the end of the asthma treatment. Thus, a psychological assessment could be included in the adolescent severe asthma work-up, involving both the adolescents and their parents.


2013 ◽  
Vol 62 (2) ◽  
pp. 179-185
Author(s):  
Olga Voldemarovna Lavrova ◽  
Yelena Andreyevna Shapovalova ◽  
Mariya Anatolyevna Petrova ◽  
Yuliya Romanovna Dymarskaya ◽  
Anna Vladimirovna Sablina

The goal of the study was the comparison pregnancy duration, delivery and height-weight ratio of newborns in females with different severity of Asthma duration and various basic therapies. Materials & methods. Study group was compounded with 1010 Asthmatic females aged 17–43 years, followed up by our staff together with gynecologists since early terms of their pregnancy. All patients were performed physical exam and functional study. As a result individual prophylaxis and treatment plan was generated for every pregnant. Results: Pulmicort-turbuhaler and SABA administration was significantly less effective in patients with moderate and severe asthma duration in comparison with fluent persistent asthma pregnants. The lowest frequency of gestoses (twice lower in comparison with Pulmicort-turbuhaler treated patients) was fixed in patients, treated with Seretide. Preterm delivery jeopardize was twice higher in Pulmicort-turbuhaler treated group. Frequency of Caesarian section was significantly higher in Pulmicort-turbuhaler treated females in comparison with females, treated with Simbicort. Average height-weight ratio in case of severe Asthma duration was lowest in patients with severe Asthma, who were administered Pulmicort-turbuhaler. Аverage weight value of kids, born by Seretide administered females, was above median value of BA females in total.


Sign in / Sign up

Export Citation Format

Share Document